Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is at $9.50 with a low of $9.38 and a high of $10.13. This range of trading makes the stock one of the day’s most volatile.
$9.38 is the stock’s 52 week low. It is trading at $9.50 a bit lower than the 50 day moving average which is $10.41 and just below the 200 day moving average of $10.41. The 50 day moving average moved down $-0.91 and the 200 day average was down $-0.91.
Short traders are feeling a little more bullish on shares of Collegium Pharmaceutical, Inc. lately as implied by the fall in short interest. The stock saw a fall in short interest of -4.73% as of August 31, 2017 from the last reporting period. Short interest fell from 7,164,589 to 6,825,997 over that timeframe. The short-interest ratio increased to 21.0 and the percentage of shorted shares is 0.23% as of August 31.
Recent Analyst Ratings
On September 11 analysts at H.C. Wainwright initiated coverage on the stock setting a rating of “Buy”. In the latest earnings report the EPS was $-3.59 and is projected to be $-3.00 for the current year with 29,566,000 shares currently outstanding. Next quarter’s EPS is expected be $-0.73 with next year’s EPS anticipated to be $-1.88.
Collegium Pharmaceutical, Inc., launched on July 01, 2014, is a specialty pharmaceutical company. The Company is involved in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS. Its DETERx platform provides extended-release drug delivery, while safeguarding against common methods of abuse and tampering, including crushing, chewing, and heating and injecting. In its DETERx technology, the Company combines active ingredients, such as oxycodone with fatty acid and waxes to form small spherical beads (microspheres) that are filled into a capsule..